RQx Pharmaceuticals signs drug discovery deal with Genentech
As per the deal, RQx will earn an up-front payment in addition to research and development milestone payments worth $111m. RQx CEO and venture partner at Avalon Venture
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.
Agilent’s commercial products include RapidFire system, designed for use in pharmaceutical and biopharmaceutical laboratories. Agilent RapidFire business director Can Ozbal said, "By using multiple RapidFire systems Ameritox is
The companies collaborated to integrate expertise in biology, advanced chemistry and technology commercialization for algae based products. Qualitas Health CTO Dr. Isaac Berzin said, "Exclusive access to Valicor’s